The invention relates to a process of preparing a pharmaceutical composition comprising bepotastine or pharmaceutically acceptable salt thereof, cortiocosteroids or pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable excipient, wherein the composition is formulated as nasal spray or nasal drop.